GOP Senator Moves to Kill Hemp Ban Delay Before November Deadline

Photo by Caleb Perez via Unsplash.

Ted Budd picked a fight this week that most of his Senate colleagues would probably rather avoid. On Monday, Aug. 3, 2026, the North Carolina Republican announced he'll file an amendment to strip a hemp-friendly delay out of the Senate's must-pass continuing resolution, H.R. 6500. Buried in that funding bill is a provision that would push the effective date of a near-total ban on intoxicating hemp products from Nov. 12 back to Dec. 11, 2026. Budd wants that cushion gone.

The stakes are not small. Without the delay, a federal ban touching a hemp product market industry groups peg at close to $30 billion goes into effect on Nov. 12 -- full stop. With it, retailers and manufacturers get another month to adjust, lobby or find a legislative fix. That one-month difference is now the subject of a floor fight as the Senate works toward final passage of the funding bill this week, with Budd's amendment sitting alongside a handful of others senators want attached before the CR clears.

What Budd's Amendment Would Actually Do

Photo by raksasok heng via Pexels.

Budd made his intentions known the way a lot of Senate business now gets telegraphed first -- on social media, on a Monday afternoon, ahead of any formal filing. His target is narrow but consequential: the newly released text of H.R. 6500, the continuing resolution meant to keep the federal government funded past the Sept. 30 end of the fiscal year by extending funding through Dec. 11. Tucked inside that stopgap bill, alongside all the routine appropriations language, is a provision that quietly delays the hemp product ban from its original Nov. 12 start date to that same Dec. 11 deadline.

Budd's amendment would simply cut that delay language out, restoring Nov. 12 as the operative date for the ban to take effect. It's a small strike-through in a massive bill, but it would eliminate the one-month grace period that hemp beverage companies, gummy makers and retailers had been counting on.

The timing matters here too. H.R. 6500 cleared a procedural vote on Monday, putting it on a track toward final passage later this week once senators finish offering and voting on amendments. That means Budd's proposal isn't a symbolic gesture filed for press purposes -- it's one of the live amendments that could actually get a floor vote before the bill is sent back to the House or to the president's desk.

How We Got to a Nov. 12 Deadline

Photo by Dad Grass via Pexels.

To understand why Nov. 12 matters at all, you have to go back to the 2018 Farm Bill, which legalized hemp nationally as long as it contained less than 0.3% delta-9 THC by dry weight. That threshold, signed into law under President Trump, is what opened the door to the hemp-derived product industry as it exists today -- everything from CBD oils to the delta-8 and delta-9 beverages now sitting on convenience store shelves in states with no adult-use marijuana program at all.

Late last year, Trump signed new legislation that redefined hemp in a much tighter way, capping total THC at 0.4 milligrams per container rather than measuring by dry weight percentage. That sounds like a technical tweak, but it isn't. A 0.4 milligram per-container cap effectively zeroes out most of the intoxicating hemp beverages, gummies and tinctures currently on the market, since many of those products are formulated with far more THC per serving than that limit allows. Industry advocates argue this new threshold would gut a hemp product economy they estimate at nearly $30 billion in annual sales.

The continuing resolution's delay provision offers a partial reprieve, but with a notable exception: synthetic cannabinoids not naturally produced by Cannabis sativa L. would still be banned immediately on Nov. 12, regardless of whether the broader delay survives. That carve-out reflects a genuine and separate concern among regulators and public health officials about lab-synthesized cannabinoids marketed as hemp-derived, which is a different problem than the naturally occurring THC products caught up in the broader ban.

Budd's Track Record on Cannabis and Hemp

Photo by Yunus Erdogdu via Pexels.

Budd didn't arrive at this fight by accident. In December, he led a group of Republican senators in sending a letter urging Trump not to move forward with rescheduling marijuana under federal law, a position that put him at odds with parts of his own party's more libertarian-leaning wing on cannabis policy. When Trump proceeded with rescheduling anyway, Budd didn't soften his stance -- he said publicly that the president had been poorly advised on the issue.

That skepticism toward loosening cannabis and hemp policy has shown up repeatedly in Budd's legislative work. In April, he introduced a bill that would require the federal government to formally track hospitalization costs tied to marijuana use, an effort aimed at building a public health data case against broader cannabis normalization. His current amendment isn't a new idea pulled from thin air, either -- it mirrors language from two earlier Budd amendments targeting this same hemp THC ban delay, both of which were offered previously but never got an actual floor vote.

Taken together, this track record positions Budd as one of the most consistent and vocal cannabis and hemp policy hawks currently serving in the Senate. Where plenty of his colleagues treat hemp regulation as a niche issue to be quietly negotiated in conference committees, Budd has made it a recurring, public priority -- and he's willing to force votes on it even when the outcome is uncertain.

The Lobbying Fight Behind the Delay

Photo by Nicolás Rueda via Pexels.

Budd isn't operating in a vacuum -- there's real money and organized lobbying on the other side of this fight. The Beverage Alcohol Merchants Coalition, which represents large retailers including Total Wine & More, has backed the Dec. 11 delay specifically to buy time for a federal regulatory framework for hemp beverages to take shape. That's a telling alliance: alcohol retailers increasingly see low-dose hemp drinks not as a competitive threat but as complementary inventory worth stocking alongside beer, wine and spirits, assuming there's a stable legal framework to sell them under.

Separately, and perhaps more consequentially for the industry's long-term future, Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) are preparing a bipartisan Senate companion bill mirroring Rep. Andy Barr's Lawful Hemp Protection Act, H.R. 9830, introduced in the House on July 22. Rather than banning intoxicating hemp products outright, that bill would establish permanent regulatory guardrails: a 21-and-over age restriction, a ban on synthetic cannabinoids, and a taxation structure similar to what applies to other regulated intoxicants.

Sheehy has described hemp regulation as one of the rare issues in the current Congress with genuine bipartisan potential -- a notable claim given how little else Republicans and Democrats agree on right now. Whether that potential translates into passed legislation before the Nov. 12 or Dec. 11 deadlines is a separate question, but it signals where the more durable policy fix is likely to come from, regardless of how this week's amendment fight shakes out.

What Happens Next

Photo by Aibek Skakov via Pexels.

The Senate is expected to vote on final passage of H.R. 6500 later this week, with Budd's amendment among several competing proposals senators will consider before that happens. The math here is straightforward even if the politics aren't: if Budd's amendment succeeds, the Dec. 11 delay language disappears entirely and the original Nov. 12 ban deadline stands as written in last year's legislation. If it fails, hemp businesses get roughly an extra month of legal breathing room while Congress continues debating permanent solutions like the Lawful Hemp Protection Act and the emerging Sheehy-Klobuchar bill.

It's worth remembering that whatever happens at the federal level, state law doesn't disappear. Hemp and intoxicating THC product rules already vary enormously from state to state -- some states have banned delta-8 and similar hemp-derived cannabinoids outright, others regulate them like alcohol, and others have left them largely unaddressed. Business owners and consumers should confirm the rules specific to their own state rather than assuming a federal outcome settles the matter locally, since it won't.

What's really riding on this vote is the difference between an abrupt shutdown and a longer runway. Thousands of hemp retailers, from small CBD shops to convenience store chains stocking THC seltzers, are watching this amendment closely because the practical difference between Nov. 12 and Dec. 11 is the difference between scrambling this fall and having a few more weeks to pivot inventory, lobby lawmakers, or wind down operations in an orderly way.

It's an odd thing to sit back and realize that a single floor amendment, offered by one senator from North Carolina, could decide whether a multibillion-dollar product category gets a one-month cushion or falls off a cliff on Nov. 12. But that's genuinely where things stand this week. Budd's amendment isn't about whether intoxicating hemp products eventually get regulated more tightly -- most people across the political spectrum seem to agree that's coming in some form. It's about timing, and timing is everything for businesses trying to plan inventory, staffing and compliance around a hard deadline.

What this fight really exposes is that hemp policy has stopped being a simple partisan dividing line and become something closer to a genuine wedge issue inside the Republican Party itself. Budd is pushing against a delay that has support from alcohol retailers and hemp beverage advocates who'd otherwise be natural GOP allies on deregulation. That's not a small development for an industry that's spent years assuming its biggest obstacles would come from the left.

Regardless of how this week's vote goes, the more durable answer to all of this probably isn't a continuing resolution rider at all -- it's the Sheehy-Klobuchar bill and the House's Lawful Hemp Protection Act, both of which are actually trying to build permanent rules rather than just buying time. Those are worth watching closely in the months ahead, since a one-month delay only postpones the real question Congress still hasn't answered: what a legal, regulated hemp product market is actually supposed to look like.